Study confirms the low likelihood that SARS-CoV-2 on hospital surfaces is infectious eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
UC Davis School of Medicine professors discuss the Pfizer-BioNTech vaccine
Microbiology and immunology professors explain the COVID-19 vaccine and what sets it apart from past vaccines
On Dec. 11, 2020, the Pfizer-BioNTech vaccine was approved for use by the Food and Drug Administration (FDA) after a series of experimental trials since mid-March. The Moderna vaccine also received emergency authorization from the FDA on Dec. 18, 2020. Barbara Shacklett, a professor at the UC Davis School of Medicine whose research focuses on cell-mediated immune responses to HIV, noted that although the vaccine hasn’t taken long to be approved, the experimental process wasn’t carried out hastily.